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Abstract 
In this paper we report the synthesis and the characterization of the novel ligand H5EPTPA-
C16 ((hydroxymethylhexadecanoyl ester)ethylenepropylenetriaminepentaacetic acid). This 
ligand was designed to chelate the GdIII ion in a kinetically and thermodynamically stable way 
while ensuring an increased water exchange rate (kex) on the GdIII complex due to steric 
compression around the water binding site. The attachment of a palmitic ester unit to the 
pendant hydroxymethyl group on the ethylenediamine bridge yields an amphiphilic conjugate 
that forms micelles in aqueous solution with a long tumbling time (τR). The critical micelle 
concentration (CMC = 0.34 mM) of the amphiphilic [Gd(EPTPA-C16)(H2O)]2‐ chelate was 
determined by variable concentration proton relaxivity measurements. A global analysis of the 
data obtained in variable temperature and multiple field 17O NMR, and 1H NMRD 
measurements allowed the determination of parameters governing relaxivity for [Gd(EPTPA-
C16)(H2O)]2‐; this is the first time that paramagnetic micelles with optimized water exchange 
are investigated. The water exchange rate was found to be kex298 = 1.7×108 s-1, very similar to 
that previously reported for the nitrobenzyl derivative [Gd(EPTPA-bz-NO2)(H2O)]2‐  (kex298 = 
1.5×108 s-1). The rotational dynamics of the micelles was analysed using the Lipari-Szabo 
approach. The micelles formed in aqueous solution show a considerable flexibility, with a local 
rotational correlation time of the GdIII segments, τlO298 = 330 ps, being much shorter than the 
global rotational correlation time of the supramolecular aggregates, τgO298 = 2100 ps. This 
internal flexibility of the micelles is responsible for the only limited increase of the proton 
relaxivity observed on micelle formation (r1 = 22.59 mM-1s-1 for the micelles vs. 9.11 mM-1s-1 
for the monomer chelate (20 MHz; 25°C)).  
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Introduction 
The success of magnetic resonance imaging (MRI) as a clinical diagnostic technique is largely 
related to the use of paramagnetic contrast agents which improve the contrast between normal 
and diseased tissues. Trivalent gadolinium chelates have shown to be the most suitable MRI 
contrast agents (CAs) [1-7]. One of the big challenges in the development of new CAs is the 
improvement of their relaxivity and their capability to target certain organs and tissues which 
would allow the clinical use of lower doses [8-9] (proton relaxivity is defined as the 
paramagnetic longitudinal proton relaxation rate enhancement due to one millimolar 
concentration of the agent). Theory predicts that slow rotation of the chelates in solution (long 
τR values) and fast water exchange between the ion coordination sphere and the bulk water 
(high kex=1/τm values, where τm is the lifetime of the water molecule in the coordination 
sphere) will lead to higher relaxivities [4,6]. Upon attachment of low molecular weight GdIII-
chelates to macromolecules, the rotation slows down and the relaxivity increases. However this 
increase is usually far from being optimal (r1max ~100 mM-1s-1 for a q=1 complex at 20-60 
MHz proton Larmor frequency) because either the bound chelate is too flexible (internal 
motions dominate) or water exchange becomes limiting (τm > T1M) [2,6]. 
Several approaches have been attempted to increase τR values in the search for high 
relaxivities. These involved the formation of covalent or non-covalent conjugates between the 
paramagnetic chelate and slowly moving substrates (dendrimers [10], proteins [11]; 
carbohydrates [12]). An appealing alternative way to increase τR is through self-assembly of 
amphiphilic GdIII-chelates forming micelles [13]. Many of these GdIII-containing assemblies 
behave as colloidal carriers which, in addition to the increased relaxivities, show good 
pharmacological characteristics [14]. They can be efficiently taken up by macrophage-rich 
tissue undergoing endocytosis/phagocytosis (liver and spleen) [15,16] and have proved to be 
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useful for diagnostic purposes [15]. Long-circulating colloidal systems with entrapped 
radiopharmaceuticals or CAs have been successful in blood-pool imaging [17-19].  
Several GdIII-based micellar systems have been designed and characterized [13, 20, 21]. In 
these systems the relaxivities were considerably improved due to the longer tumbling times in 
solution but low water exchange rates seriously cut back the relaxivity gain. 
The chelate [Gd(TRITA)(H2O)]‐  (H4TRITA  =  1,4,7,10-tetraazacyclotridecane-N,N’,N’’,N’’’-
tetraacetic acid) was reported to have a fast water exchange due to steric compression around 
the water binding site. The increased steric crowding in this chelate is achieved by replacing an 
ethylene bridge of DOTA4- (H4DOTA = 1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-
tetraacetic acid) by a propylene bridge [22]. The same strategy proved successful in 
accelerating water exchange in the GdIII-chelates of modified DTPA5- ligands (H5DTPA = 
diethylenetriamine-N,N,N’,N’’,N’’-pentaacetic acid). These ligands present one propylene 
bridge (H5EPTPA = ethylenepropylenetriamine-N,N,N’,N’’,N’’-pentaacetic acid) instead of 
the original ethylene bridge, or one coordinating propionate arm (H5DTTA-N'prop = 
diethylenetriamine-N,N,N’’,N’’-tetraacetic-N’-propionic acid) instead of the acetate arm of 
DTPA5- [23]. A different system displaying fast water exchange at the GdIII ion is based on a 
mono-amide DOTA complex, as demonstrated by Parker and co-workers [24].  
With the objective of slowing down the rotation, the fast exchanging [Gd(EPTPA)(H2O)]2- 
chelate has been attached to different generations (5,7 and 9) of PAMAM dendrimers [25]. A 
combined 17O NMR and proton relaxivity study of these systems showed that, in contrast to 
previously reported dendrimeric GdIII complexes, the proton relaxivity was indeed not at all 
limited by slow water exchange.  
In this paper we report the synthesis of the new ligand H5EPTPA-C16 
((hydroxymethylhexadecanoyl ester)ethylenepropylenetriaminepentaacetic-acid)), which was 
designed to chelate the GdIII ion in a kinetically and thermodynamically stable way [23] while 
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displaying a simultaneous optimization of the rotational correlation time and the water 
exchange rate and hence a higher relaxivity. The tumbling time of the chelate is slowed down 
upon attachment of a C-16 lipophilic chain to the -CH2OH pendant group through ester bond 
formation. Due to the capability of this amphiphilic species to form micelles in solution, its τR 
value will be substantially increased. In addition, the τm value of the GdIII-chelate is optimized 
in comparison to commercial chelates such as [Gd(DTPA)(H2O)]2-, as a consequence of an 
increased steric compression in the coordination sphere of the metal ion, brought about by the 
propylene bridge connecting two nitrogen atoms. 
The critical micelle concentration (CMC) of the amphilic [Gd(EPTPA-C16)(H2O)]2‐ chelate 
was determined by proton relaxivity measurements. In the aim of assessing the parameters that 
determine proton relaxivity, the water exchange rate and rotational correlation time in 
particular, we have carried out a variable temperature and multiple field 17O NMR and 1H 
NMRD study. The rotational dynamics of the micelles was described in terms of local and 
global motions, related to motions of the GdIII segments and of the entire micelle, respectively, 
by using the Lipari-Szabo approach in the analysis of longitudinal NMR relaxation rates.  
 
Results and Discussion 
Synthesis 
The new CA skeleton EPTPA5- has been proposed recently, which features a masked, pendant 
amine group on the ethylenediamine unit designed for conjugation to chemical moieties for 
targeting purposes and/or for the formation of macromolecular complexes.[23] In this paper we 
report a new synthetic route to the EPTPA5- skeleton bearing a hydroxymethyl group on the 
ethylenediamine unit (Scheme 1).  
 6
We envisaged that coupling a fatty acid to the hydroxymethyl group would generate the 
amphyphylic molecule 8 (EPTPA-C16) that would self-assemble in solution, thus increasing 
the tumbling time, and the relaxivity of its GdIII complex.  
The reductive amination of the Garner aldehyde 2 with the Boc-monoprotected diamine 3 is 
the key reaction in the construction of the EPTPA scaffold. The reducing agent sodium 
triacetoxyborohydride NaBH(OAc)3 proved to be highly efficient [26].   The Garner aldehyde 
2 was obtained through a high yielding three-step procedure from serine methyl ester 
hydrochloride 1 [27].  The fully protected triamine 4 was deprotected in quantitative yield in 
one step with a HCl 6 M / EtOH (1/1) mixture. The alkylation reaction required pre-titration of 
the aqueous triamine hydrochloride to neutral pH. The titration with Dowex 1X2-100-OH- 
resin revealed to be a convenient procedure. The fully deprotected triamine 5 was of analytical 
purity and was carried through without further purification. Triamine 5 was alkylated with tBu-
bromoacetate in a standard procedure [23]. The fully alkylated material 6 was coupled to 
palmitic acid through the anhydride method. The resulting ester 7 was isolated as an adduct 
with an extra molecule of palmitic acid, as demonstrated by 1H NMR spectroscopy. No 
attempts were made to purify the compound at this stage. We reasoned that it would be more 
efficient to carry this material through and to perform the final purification on the material at 
the fully deprotected stage. The deprotection with TFA/CH2Cl2 proceeded uneventfully, 
affording again the deprotected material as an adduct with an extra molecule of palmitic acid. 
The palmitic acid adduct was suspended in water and titrated to neutrality with aqueous KOH. 
This procedure allowed the removal of the insoluble potassium palmitate by filtration. The 
final compound was purified by RP C8 chromatography eluting with H2O/EtOH (100% H2O → 
100% EtOH) to afford the title material 8 in analytical purity. The hydroxymethyl group on the 
ethylenediamine unit originates from the amino acid serine. The synthesis started with the 
unnatural R-enantiomer. This synthetic route is not likely to have lead to racemization or 
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inversion of configuration on the stereogenic centre. Optical rotation measurements indicate 
that our final compound is optically active. Further studies are needed in order to confirm the 
absolute stereochemistry and the enantiomeric purity of the final compound 8. 
Determination of the critical micellar concentration (CMC) 
The amphiphilic GdIII-chelate is expected to behave as a surfactant in aqueous solution, i.e. to 
form macromolecular micellar structures. Micelle formation is characterized by the critical 
micellar concentration (CMC), the lowest concentration limit at which micelles start to appear 
in solution. We have determined the CMC value by means of 1H relaxivity measurements (60 
MHz and 25 oC). This procedure, previously established for paramagnetic micellar systems, is 
based on the variation of the water 1H longitudinal relaxation rate with increasing 
concentrations of the GdIII-chelate [21]. The measurements are performed at a frequency where 
the relaxivity is principally determined by rotation. Accordingly, micelle formation will result 
in a slower molecular tumbling and a concomitant increase of the observed proton relaxivity. 
At concentrations inferior to the CMC no aggregates form, and under these conditions, only the 
monomeric chelate contributes to the paramagnetic 1H relaxation rate measured in the solution, 
which is given by Eq. (1):  
        (1)  
where dR1  is the diamagnetic contribution to the longitudinal relaxation rate (the relaxation rate 
of pure water), ..1
anr represents the relaxivity of the free, non-aggregated GdIII-chelate (in mmol-
1s-1) and cGd is the analytical GdIII concentration. 
At concentrations superior to the CMC, the measured relaxation rate is the sum of two 
contributions, one due to the chelate as monomer (free surfactant) present at a concentration 
given by the CMC and the other due to the aggregated form (micelles). The water 1H relaxation 
rate measured for the paramagnetic solution can be then expressed as in Eq. (2): 
Gd
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where ar1  is the relaxivity of the micellar (aggregated) form. The CMC is determined from the 
plot of the paramagnetic relaxation rates vs. the GdIII concentration as shown in Figure 1, based 
on a simultaneous least-squares fit of the two straight lines. The slopes of these two lines 
define ..1
anr and ar1 , below and above the CMC, respectively. The values obtained were 
..
1
anr = 
7.79 mmol-1s-1 and ar1  = 24.21 mmol
-1s-1 (at 25 oC and 60 MHz). The CMC was found to be 
0.34±0.02 mM, which, in a comparison to previously studied, similar amphiphilic GdIII 
complexes with hydrocarbon chains, falls exactly into the range expected for a compound with 
a sixteen-carbon lipophilic tail (Figure 2) [21]. 
 
17O NMR and 1H NMRD measurements 
In order to determine the water exchange rate and assess the rotational dynamics of the 
[Gd(EPTPA-C16)(H2O)]2- chelate, we have measured variable-temperature, transverse and 
longitudinal 17O relaxation rates and chemical shifts at two magnetic fields (4.7 and 9.4 T), at a 
concentration (0.027 mol/kg) which well exceeds the CMC. Thus we consider that the 
contribution of the monomeric form to the 17O experimental data is negligible. Additionally, 
proton relaxivities were measured as a function of the Larmor frequency (NMRD profiles) at 
three different temperatures and EPR spectra were also recorded. Based on the analogy to the 
previously reported [GdIII(EPTPA-bz-NO2)(H2O)]2-, we assume [GdIII(EPTPA-C16)(H2O)]2- to 
be nine-coordinate with one inner sphere water molecule [23]. For the momomeric form of the 
chelate, we have determined the field-dependent proton relaxivities, ..1
anr , by 1H NMRD 
measurements at a concentration of 0.2 mM (below the CMC -Figure 3). NMRD profiles were 
also recorded at cGd = 2 mM concentration (above the CMC). The relaxivities of the aggregated 
form, ar1 , were calculated at each temperature and magnetic field (Figure 4c) by subtracting 
Gd
a
1
a
1
n.a
1
d
1
obs
1 Cr CMC )r(r  R  - R ×+−=
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the relaxation rate contribution of the monomer chelate, present at the concentration of the 
CMC (r1na×CMC), from the paramagnetic relaxation rate values measured at cGd = 2 mM 
concentration (R1obs - R1d), according to Eq. (3): 
  ( ) ( )CMCcCMCrRRr Gdnadobsa −×−−= /1111     (3) 
For the aggregated form of the chelate, we performed a simultaneous least-squares fit of the 
17O NMR, EPR and NMRD data, these latter calculated with Eq. (3). All the available 
experimental data (17O NMR chemical shifts, ∆ωr, longitudinal (1/T1r) and transverse (1/T2r) 
relaxation rates, the longitudinal proton relaxivities (r1) and transverse electron spin relaxation 
rates, obtained from the EPR spectra) were analysed simultaneously. The data were fitted to 
the conventional Solomon-Bloembergen-Morgan theory [7], except for the description of the 
rotational dynamics (influencing both 17O and 1H longitudinal relaxation), for which we used 
the model-free Lipari-Szabo approach [28, 29] (see appendix for all equations). Indeed, the 
longitudinal 17O relaxation rates show a distinct magnetic field dependence, which is always a 
clear indication of slow molecular motions and cannot be described by the common spectral 
density functions applied for small molecular weight chelates. According to the Lipari-Szabo 
approach, the modulation of the interaction that causes relaxation is the result of two 
statistically independent motions: a rapid local motion of the GdIII segments, with a local 
rotational correlation time τl, and a slower global motion of the entire micellar aggregate, with 
a global rotational correlation time τg. The degree of spatial restriction of the local motion with 
regard to the global rotation is given by an additional model free parameter, S2. For a totally 
free internal motion S2 equals 0, while for a local motion which is exclusively correlated to the 
global motion, S2=1.  
Given the large number of parameters involved in the analysis of the 17O NMR, EPR and 
NMRD data, some of them had to be fixed to common and physically meaningful values. For 
the distances we used rGdO = 2.5 Å (Gd electron spin and 17O nucleus distance), rGdH = 3.1 Å 
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(Gd electron spin to 1H nucleus distance) and aGdH = 3.5 Å (closest approach of the bulk water 
protons to the gadolinium). The quadrupolar coupling constant for the bound water oxygen, 
χ(1+η2/3)1/2, was fixed to 5.2 MHz [30]. The longitudinal 17O relaxation is related to motions 
of the Gd-coordinated water oxygen vector, while the proton relaxation is determined by 
motions of the Gd-coordinated water proton vector. For the ratio of the rotational correlation 
time of the Gd - Hwater and Gd - Owater vectors, τRH/τRO, similar values have been found for 
various small molecular weight monohydrated GdIII complexes, both by experimental studies 
and MD simulations (τRH/τRO = 0.65±0.2) [30,31]. This τRH/τRO ratio, within the given error, is 
considered as a general value for the ratio of the two rotational correlation times. Thus, in the 
simultaneous analysis of 17O NMR and NMRD data, we fixed the ratio of the local correlation 
times of the Gd - coordinated water proton vector (τlH) and the Gd - coordinated water oxygen 
vector (τlO) to 0.65. The global rotational correlation times obtained from oxygen and proton 
relaxation are identical (τgO = τgH). In the analysis, we fitted the rotational correlation times 
τlO298 and τgO298 characterizing the motion of the Gd - Owater vector. The experimental NMRD 
and 17O NMR data and the fitted curves for [GdIII(EPTPA-C16)(H2O)]2-are presented in Figure 
4. The X-band peak-to-peak EPR linewidths, not presented in Figure 4 but included in the fit, 
were between 440 Gauss (270 K) and 480 Gauss (316 K). The most relevant parameters 
obtained in the fit are shown in Table 1. For the electronic relaxation parameters we obtained 
the following values: τv298 = 43±5 ps and ∆2 = (0.07±0.01)×1020 s-2; Ev was fixed to 1.0 kJ/mol. 
The value of the 17O scalar coupling constant, essentially calculated from the 17O chemical 
shifts, is A/ħ = -(3.1±0.3)×106 rad s-1. The diffusion constant, DGdH298, and its activation energy, 
EDGdH, were calculated to be (28±2) × 10-10 m2 s-1 and (25±1) kJ mol-1, respectively.  
The NMRD profiles measured at three different temperatures for the non-aggregated chelate 
have also been fitted. Here, the rotational dynamics was described by the common spectral 
density functions of the Solomon-Bloembergen-Morgan theory, since the rotation is not slow 
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enough to require the Lipari-Szabo treatment. Due to the lack of 17O NMR data directly on the 
monomer form, in the fit of the NMRD profiles we fixed the water exchange rate and the 
activation enthalpy to the values obtained for the micellar form (Table 1). The electronic 
parameters calculated are τv298 = 44±8 ps and ∆2 = (0.08±0.01)×1020 s-2; Ev was fixed to 1.0 
kJ/mol. For the rotational correlation time, we obtained τrH = 200±30 ps, which corresponds to 
a value expected for a molecule of the given molecular weight (Table 2). The experimental 
NMRD profiles and the fitted curves are presented in Figure 3. 
 
Water exchange rate and rotational dynamics 
Table 2 shows proton relaxivity data, water exchange rates and rotational correlation times for 
a series of GdIII compounds [13, 22, 23, 25, 34, 35], compared to the present results for 
[Gd(EPTPA-C16)(H2O)]2‐  both in non-aggregated and aggregated forms. The water exchange 
rate of [Gd(EPTPA-C16)(H2O)]2‐, 298exk  = 170 × 10
6 s-1, is consistent with the values obtained 
for analogue GdIII EPTPA-derived chelates. In all of these compounds, steric compression 
around the water binding site leads to an accelerated water exchange in comparison to the 
DTPA-type GdIII complexes. With regard to rotational dynamics, the large difference between 
the local (330 ps) and global (2100 ps) rotational correlation time of the aggregated 
[Gd(EPTPA-C16)(H2O)]2‐ shows that the motion of a GdIII-chelate segments (characterized by 
τl) is considerably faster than that of the whole micellar assembly (τg). This, together with the 
value of the order parameter, S2 = 0.41, is a strong indication of the internal flexibility of the 
micelles. The parameter τg reflecting the global motion of the [Gd(EPTPA-C16)(H2O)]2‐ 
micellar assembly is of the same order of magnitude as those reported for amphiphilic 
[Gd(DOTACn)(H2O)]- complexes (n = 12, 14, 18) [35], but much smaller than the values for 
the large dendrimeric structures like Gadomer 17 [34] or G5-(GdEPTPA)115 [25]. The τl value 
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for the [Gd(EPTPA-C16)(H2O)]2‐ micelles is also similar to those for [Gd(DOTACn)(H2O)]- (n 
= 12, 14, 18) [35], however shorter than that for Gadomer 17, which has a less flexible 
dendrimeric structure. On the other hand, the value of the order parameter, S2 = 0.41 for 
[Gd(EPTPAC16)(H2O)]‐ is only slightly smaller than S2=0.5 calculated for Gadomer 17. 
The interaction of [Gd(EPTPAC16)(H2O)]‐ with human serum albumin was tested in a 
solution containing 4.5 % HSA. No increase in proton relaxivity was observed as compared to 
a sample without HSA (60 MHz), therefore we concluded that there is no significant 
interaction between the long chain and serum albumin.  
Conclusion 
We have devised a new, high-yielding synthetic strategy for the synthesis of a new chelator 
with the EPTPA skeleton featuring a hydroxymethyl group on the ethylenediamine unit. The 
hydroxymethyl group is available for direct conjugation to a plethora of chemical moieties 
through different linkages (ester, ether, phosphodiester, glycosidic bond, ether, etc). 
Moreover, the hydroxyl group may be easily converted to other functional groups functional 
e. g. aldehyde, carboxylic acid, azide, etc, leading to other convenient handles for 
conjugation. In this paper we have constructed a conjugate with a fatty acid to illustrate the 
concept. Furthermore, some linkages involving oxygen, e.g. ester and phosphodiester, are 
enzyme-labile, leading potentially to smart contrast agents.  
On the basis of a rational design, we have prepared a new amphiphilic GdIII-chelate, for 
which the parameters influencing relaxivity were obtained from a simultaneous analysis of 
NMRD, EPR and 17O NMR data. As a result of micellar self-assembling in aqueous solution, 
the chelate has an increased rotational correlation time. In addition, due to a steric 
compression in the inner coordination sphere of the paramagnetic ion, both the amphiphilic 
monomer and the supramolecular micellar assembly display close to optimal water exchange 
rates, two orders of magnitude superior to the CAs in clinical use. However, the self-assembly 
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of the amphiphilic monomers leads only to a modest increase in relaxivity, as the rotational 
dynamics is strongly dominated by fast local motions of the GdIII segments within the 
micelle. Clearly, as demonstrated by simulations, much higher relaxivities are achievable for 
chelates with water exchange rates of this order of magnitude, as long as the local rotational 
correlation times do not become limiting. The rigidification of the micelles is one possible 
route towards substantially higher relaxivities.  
The lipophilic tail is attached to the chelate moiety through an ester bond, which will be likely 
cleaved in the presence of lipases. Such transformation of the chelate will significantly reduce 
the observed relaxivity. This behaviour could make the [Gd(EPTPA-C16)(H2O)]2‐ chelate a 
potential responsive contrast agent, sensitive to the presence of lipases. Investigations in this 
perspective are in progress and will be reported in due course. 
  
Experimental Section 
Preparation of the complex: The GdIII chelate of EPTPA-C16 was prepared by mixing 
equimolar amounts of Gd(ClO4)3 and the ligand in a 50 mM TRIS (tris(hydroxymethyl)amino 
–methane) buffer solution (pH around 7.0) or in 150 mM MES (2-[N-
Morpholino]ethanesulfonic acid) buffer solution (pH around 6.4). A slight excess (5%) of 
ligand was used. The absence of free metal was checked through the xylenol orange test [32]. 
The Gd(ClO4)3 stock solution was made up by dissolving Gd2O3 in a slight excess of HClO4 
(Merck, p.a. 60%) in double-distilled water, followed by filtering. The pH of the stock 
solution was adjusted to 5.5 by addition of Gd2O3 and its concentration was determined by 
titration with Na2H2EDTA solution using xylenol orange as an indicator. 
Sample preparation: For the critical micellar concentration determination a 17.02 mM 
[Gd(EPTPA-C16)(H2O)]2‐ stock solution in 50 mM TRIS buffer was prepared. A series of 
[Gd(EPTPA-C16)(H2O)]2‐ solutions with different concentrations were prepared by diluting 
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the stock solution. For the NMRD profiles two solutions were prepared from the 17.02 mM 
stock solution; one below (0.2 mM) and the other above (2mM) the CMC value previously 
determined. For the 17O NMR measurements a 26.77 mmol kg-1 solution enriched to 2% 
using 10% 17O-enriched water (Yeda R&D CO., Rehovot, Israel) was prepared. 
Determination of the CMC by 1H relaxivity measurements: The concentration range for 
this determination was 12.510-0.010 mM. For each sample, longitudinal 1H relaxation rates 
were measured at 25ºC and 60MHz (1.41T) with a WP-60 electromagnet connected to a 
Bruker AC-200 console. The temperature was stabilized with a Bruker temperature control 
unit by gas flow. The longitudinal relaxation rate, 1/T1, was obtained with the inversion-
recovery method. 
NMRD measurements: The measurements were performed using a Stelar Spinmaster FFC 
NMR relaxometer (0.01-20 MHz) equipped with a VTC90 temperature control unit. The 
temperature was fixed by a gas flow. and a WP – electromagnet connected to a Bruker AC-
200 console (0.47 – 1.41 T; 20-60 MHz). At higher fields, the 1H relaxivity measurements 
were performed on Bruker Minispecs mq30 (30 MHz), mq40 (40 MHz) and mq60 (60 MHz) 
and on Bruker 50 MHz (1.18 T), 100 MHz (2.35 T) and 200 MHz (4.70 T) cryomagnets 
connected to a Bruker AC-200 console. In each case, the temperature was measured by a 
substitution technique. Longitudinal relaxation rates were measured at two different 
concentrations, one below (0.2 mM) and the other above the CMC (2mM) at 25ºC. Variable 
temperature measurements were performed at 5, 25 and 37ºC. 
EPR 
The spectra were recorded in a conventional Elexsys spectrometer E500 at X-band (9.4 
GHz). A controlled nitrogen gas flow was used to maintain a constant temperature, which 
was measured by a substitution technique. The transverse electronic relaxation rates, 1/T2e, 
were calculated from the EPR line widths according to Reuben [36]. 
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17O NMR spectroscopy: The solution samples were sealed in glass spheres adapted for 10 
mm NMR tubes to avoid susceptibility corrections of the chemical shift. Transverse and 
longitudinal 17O relaxation rates and chemical shifts were measured for temperatures between 
-1.9ºC and 52ºC. Temperatures above 60ºC were not used to avoid compound decomposition. 
Data were recorded at two different magnetic fields (9.4 T, 4.7 T). Acidified water of pH 3.4 
was used as an external reference.  
Data analysis.  
The least-squares fits on the 17O NMR and NMRD relaxation data were performed with the 
Visualiseur/Optimiseur programs on a Matlab platform version 5.3 [33].  
Materials and equipment: Chemicals were purchased from Sigma-Aldrich and used 
without further purification. Solvents used were of reagent grade and purified by usual 
methods. Reactions were monitored by TLC on Kieselgel 60 F254 (Merck) on aluminium 
support and on silica gel RP-18 on glass support (Fluka). Detection was by examination 
under UV light (254 nm), by adsorption of iodine vapour and spraying with ninhydrine. Flash 
chromatography was performed on Kieselgel 60 (Merck, mesh 230-400) and on silica gel 
100C8 – Reversed Phase (Fluka). The relevant fractions from flash chromatography were 
pooled and concentrated under reduced pressure, T<40 oC. 1H and 13C NMR spectra 
(assigned by 2D DQF-COSY and HMQC techniques) were run on a Varian Unity Plus 300 
NMR spectrometer, operating at 299.938 MHz and 75.428 MHz, for 1H and 13C, 
respectively. Chemical shifts (δ) are given in ppm relative to the CDCl3 solvent (1H, δ 7.27; 
13C 77.36) as internal standard. For 1H and 13C NMR spectra recorded in D2O, chemical 
shifts (δ) are given in ppm, respectively, relative to TSP as internal reference (1H, δ 0.0) and 
tert-butanol as external reference (13C, CH3 δ 30.29). 13C NMR spectra were proton broad-
band decoupled using a decoupling scheme.  
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Synthesis and characterisation  
Compound 2 (Garner’s aldehyde) was synthesised by a three step procedure according to the 
literature [26]. 
Synthesis of fully protected triamine  4. 
 A solution of NBoc-1,3–propanediamine 3 (1.46 g, 8.37 mmol) and Garner aldehyde 2 (1.83 
g, 7,98 mmol) in 1,2–dichloroethane (80 cm3) was stirred at room temperature for 5 minutes 
before NaBH(OAc)3 (1.72 g, 8,12 mmol) was added in small portions over 5 minutes. The 
clear solution became immediatelly cloudy and was left stirring over nitrogen for 2 hours. 
NaHCO3 (saturated solution, 100 cm3) was added, the organic phase was separated and the 
aqueous phase was extracted with dichloromethane (50 cm3). The combined organic phase 
was washed with NaHCO3 (2×80 cm3) and brine (80 cm3), dried (MgSO4) and was 
concentrated under reduced pressure to give a crude yellow oil. Purification by flash column 
chromatography (15×2.5 cm, DCM → DCM/EtOH (3:1) yielded the title compound (2.54 g, 
82%) as a colourless oil. 1H NMR (300 MHz, CDCl3): δ (ppm) = 1.44 (s, 9H, Boc); 1.48 (s, 
9H, Boc); 1.54 (m, 6H, C(CH3)2); 1.63 (m, 2H, NHCH2CH2CH2NHBoc); 2.65 (m, 1H, 
NHCHCHaHbNH) 2.71 (m, 2H, NHCH2CH2CH2NHBoc); 2.88 (m, 1H, NHCHCHaHbNH); 
3.19 (m, 2H, NHCH2CH2CH2NHBoc); 3.78-3.40 (m, 3H, OCHaHb and OCH2CH); 13C (56 
MHz, D2O): δ(ppm) = 23.06, 24.32, 26.77 and  27.56 (C(CH3)2), 28.40 (C(CH3)3); 29.68 
(NHCH2CH2CH2NHBoc); 39.26 (NHCH2CH2CH2NHBoc), 47.72 (NHCH2CH2CH2NHBoc); 
51.48 (CHCHaHbNH); 57.04 and 57.19 (OCH2CH); 66.21 (OCH2); 78.93, 79.62 and 80.20 
(C(CH3)3), 93.36 and 93.78 (C(CH3)2), 156.04 (NHC(O)OtBu); HRMS (FAB+, NBA) Calc. 
for C19H38N3O5 (M+H)+ 388.2811. Found 388.2815. 
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Synthesis of fully deprotected triamine 5: Compound 4 (2.32 g, 5.98 mmol) was stirred 
overnight at room temperature with aqueous HCl 6M/EtOH (1:1, 40 cm3). The solvent was 
removed under reduced pressure. The residue was repeatedly co-evaporated with water, 
dissolved in water (~ 20 ml) and adjusted to pH 7 with DOWEX 1X-100-OH- resin (~ 20 ml 
wet resin). The resin was filtered off and the filtrate was evaporated under reduced pressure 
to give a white vitreous solid (quantitative yield). This material was carried through without 
further purification.   1H NMR (300 MHz, CDCl3): δ (ppm) = 2.17 (qt, 2H, J = 7.5, 
NHCH2CH2CH2NH); 3.14 (t, 2H, J = 7.5, NHCH2CH2CH2NH ); 3.21 (td, 2H, J = 7.5 and 2.4 
Hz, NHCH2CH2CH2NH); 3.30 (dd, 1H, J = 13.4 and 6.6, NHCH(CH2OH)CHaHbN); 3.41 
(dd, 1H, J = 13.4 and 5.4, NHCH(CH2OH)CHaHbN), 3.72 (m, 1H, NHCH(CH2OH)CH2N), 
3.87 (m, 2H, NHCH(CHaHbOH)CH2N); MS (EI+): m/z 148.15 (M+H)+; HRMS (EI+) Calc. 
for C6H18N3O(M+H)+ 148.1450. Found 148.1450. 
 
Synthesis of fully alkylated compound 6  
To compound 5 (3.12 g, 8.06 mmol), partially dissolved in DMF, was added DIPEA (11.0 
cm3, 64.5 mmol), tert-butylbromoacetate (9.0 cm3, 60.5 mmol) and KI (1,63 g, 9.80 mmol). 
The solution became yellow and was left stirring over a period of 64 hours. The solvent was 
evaporated under reduced pressure giving rise to a yellow and a white solid. The residue was 
taken into ethyl acetate (200 cm3) and the white solid was filtered off. The organic phase was 
washed with NaHCO3 sat. sol.  (2×100 cm3), brine (100 cm3) and dried (MgSO4). The 
solvent was removed under reduced pressure giving rise to a yellow oil. Purification by flash 
chromatography (19×2.5cm) with Hexane → Hexane/Ethyl acetate (1:1) yielded the title 
compound (4.40 g, 76%) as a pale yellow oil. 1H NMR (300 MHz, CDCl3): δ (ppm) = 1.45 
(s, 45H, C(CH3)3); 1.60 (m, 2H, NCH2CH2CH2N); 2.45-2.79 (m, 6H, 
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NCH(CHaHbOH)CH2NCH2CH2CH2N); 2.93 (m, 1H, NCHCH2N); 3.211 (d, 1H, J= 6.9 Hz, 
NCH(CHaHbOH)CH2N); 3.40 (s, 6H, acetate arms); 3.44 (s, 4H, acetate arms), 3.66 (1H, dd, 
J = 11.4 and 4.8 Hz, NCH(CHaHbOH)CH2N); 13C (56 MHz, CDCl3): δ(ppm) = 26.20 
(NCH2CH2CH2N), 28.08 (C(CH3)3), 51.89 and 52.59 (NCH2CH2CH2N), 53.59 
(NCH2C(O)OtBu), 54.32 (NCHCH2N), 55.78 (NCH2C(O)OtBu), 56.08 (NCH2C(O)OtBu), 
61.97 (NCH(CHaHbOH)CH2N), 62.30 (NCH(CHaHbOH)CH2N), 80.82, 80.95 and 81.07 
(C(CH3)3), 17.59 and 171.83 (NCH2C(O)OtBu), HRMS (FAB+, NBA) Calc. for C36H68N3O11  
(M+H)+ 718.4845. Found 718.4854. 
 
Synthesis of fully-deprotected palmitic ester conjugate 8 
To a solution of compound 6 (1.68 g, 2.34 mmol) in anhydrous dichloromethane (30 cm3) 
was added palmitic anhydride (2.29 g, 4.63 mmol), pyridine (1 cm3, 12.5 mmol) and 4-
dimethylaminopyridine (28.6 mg, 0.234 mmol) and the reaction mixture was stirred at room 
temperature under a nitrogen atmosphere. After 24 hours the reaction mixture was quenched 
with cold water. To the mixture was added dichloromethane (70 cm3), the organic phase was 
separated and was washed with KHSO4 (2×100 cm3), NaHCO3 (3×100 cm3) and brine 
(1×100 cm3), dried (MgSO4) and concentrated under reduced pressure. The crude oil 
obtained was purified by flash chromatography (20×2.5 cm) with petroleum ether 40-60 → 
petroleum ether/ethyl acetate (1:1.5) to give the fully alkylated palmitic ester conjugate as an 
adduct with an extra molecule of palmitic acid 7. 1H NMR (300 MHz, CDCl3) δ (ppm) = 
0.89 (t, 6H, CH3), 1.27 (m, 48H, CH2 alkyl chain), 1.46 (s, 45H, tBu), 1.64  (m, 6H, 
overlapped signals from OC(O)CH2CH2 and NCH2CH2CH2N), 2.33 (m, 4H), 2.65 (m, 5H), 
2.85 (dd, 1H, J= 13.5 and 5.4 Hz, NCH(CH2O)CHaHbN), 3.11 (m, 1H, NCH ), 3.28 (s, 2H, 
NCH2C(O)OtBu), 3.41 (s, 4H, NCH2C(O)OtBu), 3.49 (s, 4H, NCH2C(O)OtBu), 4.12-4.24 
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(m, 2H, NCHCHaHbO); HRMS (ESI+) Calc. for C52H98N3O12   (M+H)+ 956.7150. Found 
956.7145. This material was carried through with out further purification.  
The material 7 was stirred overnight at room temperature with DCM/TFA (3:1, 15 cm3). The 
solvent was removed under reduced pressure, the residue was re-dissolved in DCM (20 cm3) 
and the solvent was removed under reduced pressure. This procedure was repeated several 
times and the material was further dried under vacuum to give a white solid. To this material 
was added distilled water (100 cm3) and the resulting suspension was adjusted to pH 7 with 
aqueous solution of KOH 0.1M. The suspension was filtrated through a nylon membrane 
filter (0.22 µm). The filtrate was concentrated under reduced pressure and the crude obtained 
was purified by flash chromatography on reversed phase RP8 silica with gradient elution 
100% H2O → 100% EtOH. The relevant fractions were pooled and the solvent was removed 
under reduced pressure to afford the title compound as a white solid (0.76 g, 48% over two 
steps). 1H NMR (300 MHz, D2O): δ (ppm) = 0.87 (t, 3H, CH3), 1.28 (m, 24H, CH2 alkyl 
chain), 1.60  (m, 2H, OC(O)CH2CH2), 2.09 (m, 2H, NCH2CH2CH2N), 2.43 (t, 2H, J = 7.2 
Hz, OC(O)CH2), 3.0-3.40 (m, 6H, overlapping signals from 
NCH(CH2OH)CHaHbNCH2CH2CH2N), 3.51 (s, 4H, acetate protons),  3.62 (m, 3 H 
overlapping signals from NCH(CH2OH)CH2N and central acetate protons), 3.77 (s, 4H, 
acetate protons), 4.26 (m, 2H, NCH(CH2O)CH2N); 13C (56 MHz, D2O): δ (ppm) = 16.68 
(CH3, alkyl chain), 23.70 (NCH2CH2CH2N), 25.35 (CH2 alkyl chain), 27.27 
(OC(O)CH2CH2), 31.58, 31.82, 32.01, 32.08, 32.23, 32.30, 32.33 and 34.59 (CH2 alkyl 
chain), 36.63 (OC(O)CH2), 45.88, 53.98 (NCH(CH2OH)CH2N), 56.22 and 56.50 
(NCH2CH2CH2N), 57.41 and 57.33-57.64 (cluster of signals from NCH2COOH), 59.92 
(NCH(CH2OC(O))CH2N), 60.10 (NCH2COOH), 64.18 (NCH(CH2OC(O))CH2N), 174.00 
(C(O), ester), 176.16, 178.57 and 178.98 (C(O), carboxylic acid). MS (ESI+): HRMS (ESI) 
Calc. for C32H58N3O12 (M+H)+ 676.4001. Found 676.4015. 
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Table 1S: Transverse relaxation rate enhancement for [Gd(EPTPA-C16)(H2O)]2‐ solutions 
with different Gd(III) concentrations.  
Table 2S: Proton relaxivities for a 0.2 mM [Gd(EPTPA-C16)(H2O)]2‐ solution (non 
aggregated form). 
Table 3S: Proton relaxivities in 2 mM [Gd(EPTPA-C16)(H2O)]2‐ (aggregated form). 
Table 4S: Proton relaxivities resulting from the micellar form calculated using the equation 
( ) ( )cmcc/cmcrRRr Gdn.a.1d1obs1a1 −×−−= . 
Table 5S: Variable temperature reduced transverse and longitudinal 17O relaxation rates and 
chemical shifts of [Gd(EPTPA-C16)(H2O)]2‐ solution at 9.4 T. cGd = 26,77mmol/Kg; Pm = 
4.81×10-4 
Table 6S: Variable temperature reduced transverse and longitudinal 17O relaxation rates and 
chemical shifts of [Gd(EPTPA-C16)(H2O)]2‐ solution at 4.7T. cGd = 26.77 mmol/kg; Pm = 
4.81×10-4. 
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Table 1. Parameters obtained from the simultaneous fit of 17O NMR, EPR and 1H NMRD 
data for the aggregated form of the [GdEPTPAC16(H2O)]2- complex.  
 
 
Parameter  
kex298 / 106s-1 170±30 
∆H‡ / kJmol-1 23.6±1.0 
τg298 / ps 2100±200 
Eg / kJmol-1 19.3±1.0 
τl / ps 330±40 
El / kJmol-1 49.0±2.0 
S2 0.41±0.08 
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Table 2 – Relaxivity (at 20 MHz and 25 oC) and parameters determining relaxivity for 
selected GdIII complexes. 
 298
exk /
(x106 s-1
τgO 
 (ps) 
τlO   
(ps) 
S2 r1  
(mM-1s-1) 
Small molecular weight chelates      
[Gd(EPTPA-bz-NO2)(H2O)] 2‐ [23] 150 τRO = 122 − - 4.73 
[Gd(EPTPA)(H2O)]2‐ [23]  330 τRO = 75 − -  
[Gd(TRITA)(H2O)]‐ [22]  270 τRO = 82    − -  
[Gd(EPTPA-C16)(H2O)]2‐ a, b  170 τRH = 200 − - 9.11 
Dendrimers      
Gadomer 17 [34] 1.0 3050 760 0.50 16.46 
G5-(GdEPTPA)115 [25] 150 4040 150 0.43 23.9 
c 
Micelles      
[Gd(DOTASAC12(H2O)]‐ [13] 4.8 920 - - 18.03 
[Gd(DOTAC10)(H2O)]‐ [35] 4.8 τRO = 470 - - 9.32 
[Gd(DOTAC12)(H2O)]‐ [35] 4.8 1600 430 0.23 17.24 
[Gd(DOTAC14)(H2O)]‐ [35] 4.8 2220 820 0.17 21.45 
[Gd(DOTASAC18)(H2O)]‐ [35]  4.8 2810 330 0.28 20.72 
[Gd(EPTPAC16)(H2O)]‐ a  170 2100 330 0.41 22.59 
 
a This work 
b non-aggregated form 
c 37 oC 
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Scheme 1. Synthetic route for the synthesis of hydroxymethy(EPTA) palmitoyl ester 
conjugate. a) NaBH(OAc)3/1,2-dichloroethane; b) i) HCl (aq. sol. 6M)/EtOH (1/1), ii) 
titration to pH 7 with Dowex1-X2-100-OH-; c) tBu-bromoacetate, DIPEA, KI/DMF; d) 
palmitic anhydride, Py, DMAP/CH2Cl2; e) i) TFA/CH2Cl2 (3/1), ii) titration to pH 7.0 with 
aq. KOH, iii) RPC8  flash chromatography. 
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Figure Legends  
 
Figure 1 - Variation of the water 1H longitudinal relaxation rate versus the total GdIII 
concentration at 60MHz and 25ºC for [Gd(EPTPA-C16)(H2O)]2‐, and least-squares fit 
according to Equation (2). 
 
Figure 2 - The CMC obtained for [Gd(EPTPA-C16)(H2O)]2‐ is in accordance with the values 
for previously reported systems. 
 
Figure 3 - 1H nuclear magnetic relaxation dispersion profiles of the monomer form of 
[Gd(EPTPA-C16)(H2O)]2‐ (0.2 mM). 5°C (○), 25 °C (□) and 37 °C (∇). 
 
Figure 4 – Temperature dependence of (a) reduced transverse and longitudinal 17O 
relaxation rates 1/T2r and 1/T1r, respectively; B = 9.4 T (ln(1/T1r): □, (ln(1/T2r): ○ and B = 4.7 
T (ln(1/T1r): ∇, (ln(1/T2r): +; (b) reduced chemical shifts ∆ωr (B = 9.4 T: □ and B = 4.7  T: ∇) 
of [Gd(EPTPA-C16)(H2O)]2‐  (cGd = 26.77 mmolkg-1). (c) 1H nuclear magnetic relaxation 
dispersion profiles of the aggregated form (2 mM), recorded at 5 ºC (○), 25 ºC (□), 37 ºC (∇). 
The lines represent the least-squares fit of the data points as explained in the text.  
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Figure 1 - Variation of the water 1H longitudinal relaxation rate versus the total GdIII 
concentration at 60MHz and 25ºC for [Gd(EPTPA-C16)(H2O)]2‐, and least-squares fit 
according to Equation (2). 
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Figure 2 - The CMC obtained for [Gd(EPTPA-C16)(H2O)]2‐ is in accordance with the values 
for previously reported systems.[35] 
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Figure 3 - 1H nuclear magnetic relaxation dispersion profiles of the monomer form of 
[Gd(EPTPA-C16)(H2O)]2‐ (0.2 mM). 5°C (○), 25 °C (□) and 37 °C (∇). 
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Figure 4 – Temperature dependence of (a) reduced transverse and longitudinal 17O 
relaxation rates 1/T2r and 1/T1r, respectively; B = 9.4 T (ln(1/T1r): □, (ln(1/T2r): ○ and B = 4.7 
T (ln(1/T1r): ∇, (ln(1/T2r): +; (b) reduced chemical shifts ∆ωr (B = 9.4 T: □ and B = 4.7  T: ∇) 
of [Gd(EPTPA-C16)(H2O)]2‐  (cGd = 26.77 mmolkg-1). (c) 1H nuclear magnetic relaxation 
dispersion profiles of the aggregated form (2 mM), recorded at 5 ºC (○), 25 ºC (□), 37 ºC (∇). 
The lines represent the least-squares fit of the data points as explained in the text.  
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Supporting information 
Equations used for the analysis of NMRD, EPR and 17O NMR data. 
17O NMR spectroscopy 
From the measured 17O NMR relaxation rates and angular frequencies of the paramagnetic 
solutions, 1/T1, 1/T2 and ω, and of the acidified water reference, 1/T1A, 1/T2A and ωΑ, one can 
calculate the reduced relaxation rates and chemical shift, 1/T1r, 1/T2r and ∆ωr (Eq. 1-3), where 
1/T1m, 1/T2m are the relaxation rates of the bound water and ∆ωm is the chemical shift 
difference between bound and bulk water, τm is the mean residence time or the inverse of the 
water exchange rate kex and Pm is the mole fraction of the bound water.[1,2] 
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Previous studies have shown that outer sphere contributions to the 17O relaxation rates are 
negligible.[3] Eqs. 1 and 2 can be further simplified:  
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1  
T τ+=1
1  (4) 
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1  (5) 
The exchange rate is supposed to assume the Eyring equation. In Eq. 6 ∆S‡ and ∆H‡ are the 
entropy and enthalpy of activation for the water exchange process, and kex298  is the exchange 
rate at 298.15 K. 
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In the transverse relaxation the scalar contribution, 1/T2sc, is the most important [Eq. 7]. 
1/τs1 is the sum of the exchange rate constant and the electron spin relaxation rate.  
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The 17O longitudinal relaxation rates in Gd(III) solutions are the sum of the contributions 
of the dipole-dipole and quadrupolar (in the approximation developed by Halle) 
mechanisms as expressed by Eq. 10-12 for non-extreme narrowing conditions, where γS is 
the electron and γI is the nuclear gyromagnetic ratio (γS = 1.76×1011 rad s-1 T-1, γI =-3.626×
107 rad s-1 T-1), rGdO is the effective distance between the electron charge and the 17O 
nucleus, I is the nuclear spin (5/2 for 17O), χ is the quadrupolar coupling constant and η is 
an asymmetry parameter : 
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In Eq. 3, the chemical shift of the bound water molecule, ∆ωm, depends on the hyperfine 
interaction between the Gd(III) electron spin and the 17O nucleus and is directly proportional 
to the scalar coupling constant, h
A , as expressed in Eq. 11.[4] 
h
A
Tk3
B)S(Sg
B
BL
m
1+µ=ω∆  (11) 
The isotopic Landé g factor is equal to 2.0 for the Gd(III), B represents the magnetic 
field, and kB is the Boltzmann constant. 
The outer sphere term of the chemical shift was found proportional to ∆ωm, through an 
empirical constant Cos. [5] 
mosos C ω∆=ω∆  (12) 
For slowly rotating species, the spectral density functions are described the Lipari-Szabo 
approach.[6,7] In this model we distinguish two statistically independent motions; a rapid local 
motion with a correlation time τl and a slower global motion with a correlation time τg. 
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Supposing the global molecular reorientation is isotropic, the relevant spectral density 
functions are expressed as in Eq. 13-16, where the general order parameter S2 describes the 
degree of spatial restriction of the local motion. If the local motion is isotropic, S2 = 0; if the 
rotational dynamics is only governed by the global motion, S2 = 1.  
( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛
τω+
τ−+τω+
τ=τω 2
1
2
1
2
2
1
2
1
2
1
1
1
1 dI
d
gdI
gd
dI
)(
;J
SS
 (13) 
( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛
τω+
τ−+τω+
τ=τω 2
2
2
2
2
2
2
2
2
2
2
1
1
1 dS
d
gdS
gd
dS
)(
;J
SS
 (14) 
iegmdig T
1111 +τ+τ=τ                  i = 1, 2 (15) 
lg τ
+τ=τ
111  (16) 
⎟⎟⎠
⎞
⎜⎜⎝
⎛
τω+
τ−+τω+
τ=ω 222
2
222
2
1
1
1 IgI
g
Ii
i
)(
i
)(J S
S
                 i = 1, 2 (17) 
 
 
 
1H-NMRD 
The measured longitudinal proton relaxation rate, obs1R  is the sum of a paramagnetic and a 
diamagnetic contribution as expressed in Eq. 18, where r1 is the proton relaxivity: 
][Gd r  R  R  RR 31
dpdobs ++=+= 1111  (18) 
The relaxivity can be divided into an inner and an outer sphere term as follows: 
1os1is1 rrr +=  (19) 
The inner sphere term is given in Eq. 20, where q is the number of inner sphere water 
molecules [8].  
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The longitudinal relaxation rate of inner sphere protons, 1/T1mH is expressed by Eq. 21, where 
rGdH is the effective distance between the electron charge and the 1H nucleus, ωI is the proton 
resonance frequency and ωS is the Larmor frequency of the Gd(III) electron spin. 
 36
( ) ( )[ ]216
2222
0
1
731
415
21
dSdI
GdH
SI
H
m
;J;J)S(S
rT
τω+τω×+γγ⎟⎠
⎞⎜⎝
⎛
π
µ= h  (21) 
iemdi T
1111 +τ+τ=τ  (22) 
The spectral density functions are given by Eq. 13-15.  
The longitudinal and transverse electronic relaxation rates, 1/T1e and 1/T2e are expressed by 
Eq. 23-24, where τV is the electronic correlation time for the modulation of the zero-field-
splitting interaction, EV the corresponding activation energy and ∆2 is the mean square zero-
field-splitting energy. We assumed a simple exponential dependence of τV versus 1/T as 
written in Eq. 29. 
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The outer-sphere contribution can be described by Eq. 26 where NA is the Avogadro constant, 
and Jos is its associated spectral density function [9,10].  
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The diffusion coefficient for the diffusion of a water proton away from a Gd(III) complex, 
DGdH, is assumed to obey an exponential law versus the inverse of the temperature, with an 
activation energy EGdH, as given in Eq. 28. 298GdHD  is the diffusion coefficient at 298.15K. 
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Table 1S: Longitudinal water proton relaxation rate enhancement for [Gd(EPTPA-
C16)(H2O)]2‐ solutions with different GdIII concentrations. (a the diamagnetic contribution to 
the longitudinal relaxation rate results from a 50 mM TRIS buffer solution). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Gd3+]/mM R1p-R1da/ms-1 
7.148 172.6 
4.279 87.96 
1.872 42.37 
0.745 12.86 
0.511 7.492 
0.397 5.110 
0.248 2.020 
0.200 1.768 
0.111 0.704 
0.100 0.557 
0.074 0.404 
0.049 0.277 
0.037 0.157 
0.010 0.009 
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Table 2S: Proton relaxivities for a 0.2 mM [Gd(EPTPA-C16)(H2O)]2‐ solution (non 
aggregated form). 
 
Frequency/MHz 37ºC 25ºC 5ºC 
20.00 6.68 9.11 14.38 
14.80 6.78 9.75 15.07 
10.90 7.30 11.08 14.77 
8.03 7.91 11.62 16.01 
5.93 9.23 12.56 17.77 
4.37 9.99 13.14 18.61 
3.23 10.91 14.32 19.81 
2.38 11.75 15.59 21.17 
1.76 12.49 15.97 21.67 
1.30 13.07 16.78 21.82 
0.96 13.46 16.97 21.98 
0.71 13.75 17.03 22.29 
0.52 13.99 17.06 22.37 
0.38 14.17 17.09 22.55 
0.28 14.22 17.09 22.55 
0.21 14.38 17.09 22.54 
0.15 14.43 17.06 22.57 
0.11 14.51 17.22 22.59 
0.08 14.54 17.03 22.54 
0.06 14.67 17.06 22.51 
0.05 14.57 17.09 22.56 
0.03 14.62 17.09 22.61 
0.03 14.75 17.09 22.60 
0.02 14.78 17.06 22.56 
0.01 14.78 17.06 22.56 
0.01 14.78 17.06 22.55 
30.00 6.61 8.79 14.02 
40.00 6.58 8.96 15.03 
60.00 6.53 8.78 15.00 
200.00 6.30 8.62 12.09 
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 Table 3S: Proton relaxivities in 2 mM [Gd(EPTPA-C16)(H2O)]2‐ 
 37ºC 25ºC 5ºC 
20.00 12.73 19.73 35.79 
14.76 11.78 18.50 32.14 
10.89 11.16 17.22 28.20 
8.03 10.85 15.88 24.94 
5.93 10.62 14.67 21.55 
4.37 10.45 14.07 20.19 
3.23 10.79 14.25 20.05 
2.38 11.47 15.02 20.75 
1.76 11.95 15.77 21.70 
1.30 12.54 16.57 22.69 
0.96 13.05 17.28 23.72 
0.71 13.37 17.85 24.65 
0.52 13.66 18.35 25.25 
0.38 13.86 18.68 25.72 
0.28 13.94 18.82 26.14 
0.21 14.05 18.97 26.34 
0.15 14.09 19.03 26.54 
0.11 14.07 19.05 26.55 
0.08 14.06 19.12 26.54 
0.06 14.10 19.08 26.62 
0.05 14.13 19.17 26.55 
0.03 14.05 19.15 26.62 
0.02 14.09 19.12 26.67 
0.02 14.13 19.17 26.55 
0.01 14.15 19.13 26.60 
0.01 14.09 19.17 26.57 
30.00 14.87 21.42 35.84 
40.00 14.94 21.88 34.39 
60.00 14.10 19.84 26.79 
200.00 8.49 9.23 10.11 
400.00 5.10 5.69 6.38 
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Table 4S: Proton relaxivities resulting from the micellar form calculated using the equation 
( ) ( )cmcc/cmcrRRr Gdn.a.1d1obs1a1 −×−−= . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Frequency/MHz 5ºC 25ºC 37ºC 
20.000 40.17 21.91 13.97 
14.800 35.63 20.29 12.80 
10.900 30.95 18.47 11.95 
8.030 26.76 16.76 11.45 
5.930 22.33 15.10 10.91 
4.370 20.51 14.26 10.54 
3.230 20.10 14.24 10.76 
2.380 20.67 14.90 11.41 
1.760 21.71 15.73 11.84 
1.300 22.86 16.52 12.44 
0.956 24.08 17.35 12.97 
0.706 25.14 18.02 13.29 
0.521 25.84 18.61 13.60 
0.384 26.37 19.01 13.79 
0.283 26.87 19.17 13.88 
0.209 27.11 19.35 13.98 
0.154 27.35 19.44 14.02 
0.114 27.37 19.42 13.98 
0.084 27.35 19.54 13.97 
0.062 27.45 19.50 13.99 
0.046 27.37 19.59 14.03 
0.034 27.45 19.57 13.93 
0.025 27.51 19.53 13.96 
0.018 27.37 19.60 14.00 
0.014 27.43 19.56 14.03 
0.010 27.39 19.60 13.95 
30.000 40.30 24.01 16.56 
40.000 38.35 24.52 16.65 
60.000 29.20 22.11 15.65 
200.00 9.71 9.36 8.94 
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Table 5S: Variable temperature reduced transverse and longitudinal 17O relaxation rates and chemical shifts of [Gd(EPTPA-C16)(H2O)]2‐ solution 
at 9.4T. cGd = 26,77mmol/Kg; Pm = 4.81×10-4 
 
 
 
 
 
 
Table 6: Variable temperature reduced transverse and longitudinal 17O relaxation rates and chemical shifts of [Gd(EPTPA-C16)(H2O)]2‐ solution at 
4.7T. cGd = 26.77mmol/kg; Pm = 4.81×10-4. 
 
 
 
 
T/K 1000/T T1/s (ref) T1/s ln(1/T1r) T2/s (ref) T2/s ln(1/T2r) ref /Hz frec /Hz ∆ωr /Hz
308.1 3.25 9.64E-03 6.94E-03 11.34 9.09E-03 3.89E-03 12.63 447.7 393.9 -7.03E+05
287.0 3.48 5.32E-03 4.03E-03 11.74 5.39E-03 2.11E-03 13.30 495.3 440.6 -7.16E+05
293.8 3.40 6.45E-03 4.86E-03 11.57 6.47E-03 2.63E-03 13.06 483.2 421.8 -8.02E+05
300.6 3.33 7.66E-03 5.64E-03 11.49 7.80E-03 3.29E-03 12.81 462.8 400.5 -8.15E+05
314.1 3.18 1.10E-02 8.22E-03 11.08 1.03E-02 4.87E-03 12.33 436.3 378.2 -7.60E+05
281.0 3.56 4.31E-03 3.23E-03 11.99 4.32E-03 1.76E-03 13.46 513.4 455.8 -7.53E+05
274.5 3.64 3.39E-03 2.71E-03 11.94 3.46E-03 1.46E-03 13.62 533.7 478.7 -7.19E+05
T/K 1000/T T1/s (ref) T1/s ln(1/T1r) T2/s (ref) T2/s ln(1/T2r) ref /Hz frec /Hz ∆ωr /Hz
306.6 3.26 8.98E-03 6.52E-03 11.38 8.95E-03 4.05E-03 12.55 -529. 9 -556.7 -3.51E+05
279.8 3.57 4.07E-03 2.85E-03 12.30 4.05E-03 1.70E-03 13.48 -497.4 -520.3 -2.99E+05
287.8 3.47 5.38E-03 3.71E-03 12.07 5.35E-03 2.19E-03 13.24 -506.5 -530.8 -3.18E+05
297.2 3.36 7.05E-03 4.98E-03 11.72 6.97E-03 2.99E-03 12.89 -515.8 -544.8 -3.79E+05
316.1 3.16 1.11E-02 8.41E-03 10.99 1.10E-02 5.34E-03 12.21 -540.5 -566.8 -3.44E+05
325.2 3.08 1.34E-02 1.04E-02 10.70 1.32E-02 6.96E-03 11.86 -554.7 -578.6 -3.12E+05
271.3 3.69 2.91E-03 2.19E-03 12.36 2.91E-03 1.31E-03 13.68 -485.8 -506.9 -2.76E+05
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